ECI Abstract submission

Meet us in-person in Geneva, Switzerland or join us online !

Important Deadlines:

  • 01 February 2023: Opening of the Abstract Submission
  • 22 February 2023: ORAL ABSTRACT SUBMISSION DEADLINE
    Abstracts submitted after this deadline but prior to 31 July 2023 will be considered for poster only

G2MC Early Career Investigators Forum (ECIF)

(formerly called Young Investigators Forum)

on October 2-4, 2023

Potential Early Career Investigator (ECI) participants (young and/or new to the field of genomic medicine) (graduate students, postdocs, and junior faculty within 2 years of their postdoc, residency, or fellowship, or investigators new to genomic medicine within past two years) are strongly encouraged to present results of their own original work. Abstracts can only be submitted through this Online Submission Module, and submitters should also register to attend the meeting through the Conference Registration website tab.

G2MC will cover the registration fee and lodging for the ECIs selected for the Podium presentation and for the flash talks. G2MC also will apply for a travel grant to cover part of the selected ECIs travel costs to provide assistance so they can attend in person. If you don’t have the opportunity to travel, we would accept a virtual presentation, even if an in-person experience is recommended..

Up to ten (10) abstracts will be selected by our ECIF Abstract Review Committee for the Podium presentations and up to 20 chosen to participate in the Flash Talk session.  All qualified abstracts will be chosen for poster presentation.

The ECIF Abstract Review Committee will also make available brief biographies through Google Docs to the other attending Early Career Investigators. We will ask you to become familiar with your colleagues to identify those with similar interests.

 The 3 best oral presentations and the 3 best posters will be awarded.

Abstract Submission Rules

General Policies:

  • ORAL ABSTRACT SUBMISSION DEADLINE 22 February 2023
  • Abstracts submitted after this deadline but prior to 31 July 2023 will be considered for poster only.
  • Abstracts are accepted in the English language only.
  • Each abstract will be reviewed by the ECIF Abstract Review Committee for acceptance as a Podium Presentation or Flash Talk. All qualified abstracts will be chosen for a Poster Presentation 
  • Successfully submitted abstracts will be acknowledged by email including an abstract reference number, which should be quoted in all correspondence
  • The ECI of the accepted abstract must be registered as a delegate within the Conference registration period.
  • The poster presentation is only for registered ECIs
  • The Podium presentation and questions will be limited to 10 minutes per ECI
  • ECI Curriculum Vitae and ECI brief biographie: should be no more than 300 words
  • A standard poster template will be provided for the E-format with the notification of acceptance
  • All abstracts accepted for oral or poster presentations will be available for open access on the G2MC’s website unless otherwise requested by the authors.

Selection Criteria:

  • Relevance to the field of genomic medicine
  • Relevance to a low and middle income (LMIC) problem that could be addressed with this implementation
  • Quality of the abstract content – description of the scientific approach and presentation of the data

Abstract Format:

  • Title of Abstract: Please avoid abbreviations, if possible
  • Maximum 300 words excluding names, affiliations, disclosures, and keywords.
  • Provide 5 five Keywords at the end of your abstract
  • Submitted abstracts should contain recent scientific, educational and technological developments pertaining to genomic medicine implementation in limited-resource settings.
  • The use of tables, graphs and other types of images is not allowed in the abstract submission (of course welcome in poster and presentation).
  • The abstract should follow this structure:

Background & Objectives [Do not repeat the title]:

Method(s) and Results:

Conclusions (Significance and Impact of the Study):

Conflict of interest disclosure: State any potential conflicts of interest. If none, then please state: The authors declare no potential conflicts of interest, whether scientific, financial and personal.

Keywords: [please provide five]

Abstract Submission Instructions:

  1. Click here to enter the system.
  2. If this is the first time you log on the G2MC2023 abstracts platform, please click « Create new account ». This account will allow you to access the platform to edit and submit your abstract(s)!
  3. Follow the procedure to create your account and password.
  4. You are now on the home page of the platform. Click on « Details » and follow the procedure.
  5. Now all the options appear in the main menu and you will be able to submit your abstract. Click on « Abstract submission »
  6. Enter the title of the abstract, your preferred presentation method (oral, poster or both), and the details of your co-authors, the affiliations.
  7. Enter your abstract. Max. 300 words excluding names, affiliations, disclosures, and keywords.
  8. Remember to provide 5 five Keywords at the end of your abstract
  9. Enter the ECI bio: should be no more than 300 words
  10. Upload the ECI Curriculum Vitae
  11. Click Proceed and review the abstract submitted.
  12. Click « Submit » to submit your abstract or « save as a draft ».  You cannot edit a submitted abstract.

Please remember to submit you draft(s) before the deadline (22 February 2023) otherwise the Reviewing Committee will not be able to review it.